FF
PLRX icon

FourThought Financial’s Pliant Therapeutics PLRX Stock Holding History

FourThought Financial’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$17K Buy
+809
New +$15.5K ﹤0.01% 904

Other funds holding PLRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

FourThought Financial's PLRX Position: Q3 2022 in Review

FourThought Financial opened a new position in Pliant Therapeutics (PLRX) in Q3 2022: 809 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #904 among its holdings.

110 funds tracked by Wall St. Rank hold PLRX as of Q3 2022.

  • FourThought Financial held 809 shares of Pliant Therapeutics worth $17K as of Q3 2022.
  • Pliant Therapeutics was a new FourThought Financial position in Q3 2022.
  • Pliant Therapeutics made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #904 holding.
  • 110 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.